-
Eli Crane Defeats Jonathan Nez in Tight Arizona Congressional Race
-
David Walliams Identified as Celebrity in Sexual Misconduct Allegations After Legal Bid
-
Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
-
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
-
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
-
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE
-
Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
-
Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift
-
KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
-
Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
-
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
-
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
-
Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
-
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
-
Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
-
Aztec Drills 70.1 Meters of 0.80 g/t AuEq (0.49 g/t Au and 16.85 g/t Ag) from Surface in TR26-54 at the Tombstone Project, Arizona
-
Silicon Publishing Launches Prism, Bringing AI-Assisted Automation to Database Publishing
-
Zeb Nickel Commences Diamond Drilling at the Zeb Nickel Project
-
Aston Bay Announces Pre-Feasibility Study Results and Maiden Mineral Reserve for the Storm Copper Project, Nunavut
-
Electrovaya to Participate in Upcoming Investor Conferences
-
Moderna to Present at Upcoming Conference in November 2026
-
INEO Invited to 15th Annual ROTH Technology Conference in New York
-
Odyssey Behavioral Healthcare Launches Virtual Intensive Outpatient Mental Health Treatment for Adults
-
Nextech3D.ai to Report Fiscal Second Quarter 2027 Financial Results and Host Investor Webinar on November 19, 2026 at 4:30 PM ET
-
Adcore Reports Third Quarter 2026 Results: Gross Margin Rises to 64%, Operating Loss Halved, Cash Up to $4.3 Million as Restructuring Takes Hold
-
Sterling Metals Announces Fully Allocated Private Placement of Units, Flow-Through Shares and Charity Flow-Through Units
-
Wash100 Award, GovCon Industry's Highest Honor, Opens Nominations for 2027 Season
-
Greene Concepts Highlights Groundwater Resources and Commercial Opportunities
-
SNZweig Forms AEC Industry Advisory Council
-
Allstar Health Brands Confirms MLS NEXT Expansion Bid to Anchor a Permanent Training Structure and a Professional Pathway
-
BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
-
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations
-
Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
-
Cardiff Lexington To Report Third Quarter 2026 Financial Results and Host Conference Call on Monday, November 16, 2026
-
ATWEC Technologies, Inc. (OTCID:ATWT) Reports Third Quarter 2026 Revenue of $12.46 Million, Up 37% Year-over-Year
-
ByNext Joins the Bilt Neighborhood: Reaching More Customers by Integrating Its Technology with Bilt Neighborhood OS
-
Your Patients Are Asking AI About You. AimwellBio Lets Every Physician See the Answer, Free.
-
Peraso to Showcase DUNE 60 GHz Wireless Platform at Africa Tech Festival 2026
-
Jerash Holdings Reports Fiscal 2027 Second Quarter Financial Results
-
SMX Advances Development of its Scientific Intelligence, an AI-Powered Platform Intended to Create a Comprehensive Codex for Chemical Agents, Additives and Supplements
-
Innovative Menopause Medicine from JASTLabs Advances Patent Protection Internationally
-
Kalm with Kava and Pū'iwa Farms Hawai'i Bring Fresh Frozen Hawaiian Kava to Market
-
ClearSign Receives Order for "M1" Series Burner from Tulsa Heaters Midstream (THM)
-
Berwyn Group Launches BerwynAPI, Bringing Real-Time Death Confirmation to a Broad Variety of Industries Including Financial Services, Insurance and Healthcare
-
Team Montlick Wins Class 2 World Championship Title in Key West
Medisafe Launches VIA: AI Voice Tech That Supercharges Patient Engagement and Slashes Enrollment Friction
Pharma’s $5B Fix: Always-On Voice That Turns Support Programs into Growth Engines
BOSTON, MA / ACCESS Newswire / April 22, 2025 / Medisafe today launched VIA (Voice Intelligent Agent) - a breakthrough AI voice assistant designed to fix pharma's $5B patient support gap and transform how specialty brands activate, engage, and retain patients.
It's not a bot. It's a breakthrough. VIA represents a new frontier in AI-powered engagement, built for specialty and complex care. If your brand is struggling with program activation or patient reach, it's time to put a voice to the solution.
In conjunction with existing apps, portals and programs, VIA is a fully integrated omnichannel AI solution that reaches patients where they are: through proactive, empathetic voice calls that feel human, not robotic. VIA uses humanized voice outreach to guide patients through onboarding, adherence, and access - while integrating with brand hubs and CRM systems for seamless pharma deployment.
Medisafe VIA is multilingual and supports a range of use cases for healthcare companies - including enrolling in a digital companion program, adherence monitoring, symptom checking, and insurance re-verification - making it a versatile tool for addressing diverse patient needs across regions and care models.
"VIA is the missing link between support programs and the patients who need them," said Rotem Shor, co-founder and CTO of Medisafe. "It is the voice that turns confusion into clarity and how we make patient support human again at scale."
Solving The $5B Black Hole in Patient Support
Pharma spends $5 billion a year on patient support programs - yet only 3% of patients use them. Why? Because most patients don't know they exist or can't navigate the onboarding maze.
VIA flips the script with direct, intelligent outreach.
No extra apps to download.
No extra portals to log into.
Just a humanized voice call - guiding patients, step by step.
And it's not just a voicebot. VIA integrates the full Medisafe experience across voice, SMS, app, and web, which is especially impactful for specialty and rare disease brands where every patient touchpoint matters. VIA has the potential to unlock millions in otherwise lost revenue by bridging the support-to-patient gap.
Why Now? Because the AI Future Is Already Here
Patients already expect seamless, intelligent, and human-centered care - and Medisafe VIA delivers exactly that. It's time to act.
For example, Mayo Clinic reports the use of AI-remote monitoring has resulted in a 40% reduction in readmissions, and Cleveland Clinic is seeing a 94% accuracy rate with its AI-powered virtual triage system.
As digital health redefines the standards of connection and outcomes, organizations that delay risk falling behind. Pharma brands that delay risk losing engagement today, not tomorrow. VIA meets patients where they are, right now - before someone else does.
VIA is designed to plug directly into Medisafe partner brand hubs, CRM systems, and patient support workflows - accelerating implementation without disruption. Specifically, today's release means Medisafe partners can:
Boost enrollment through proactive, guided voice outreach
Improve adherence and reduce no-shows across health systems and provider networks
Deliver timely, frictionless support to patients and caregivers via familiar channels
"VIA represents a critical leap forward in making healthcare engagement more human, accessible, and effective," said Stacey Wasserman, Chief Commercial Officer, Medisafe. "And VIA isn't just patient engagement - it's a revenue unlock for brands struggling to connect support to outcomes,"
Available Now
VIA integrates with Medisafe partners in as little as 30 days and complies with applicable law and regulation - reducing risk while accelerating value. Ready to turn your support program into a growth engine? Meet our team at Asembia 2025 or see more at MedisafeVIA.com .
About Medisafe
Medisafe is the leading medication engagement company that empowers patients to seamlessly manage their treatment journey and holistic health to drive outcomes, while providing real-time intelligence from a database of billions of data points. By combining advanced technology with behavioral science, Medisafe's multiple options support patients, providers, and payers at-scale by supporting better engagement, health management, and outcomes. Over 13M registered patients and caregivers rely on Medisafe's HIPAA and GDPR compliant solution, which is also ISO 27001:2022 and ISO 13845 certified.
Media Contact
[email protected]
Sources
https://www.netguru.com/blog/ai-in-telehealth
https://www.fiercepharma.com/marketing/pharmas-return-5-billion-spent-yearly-patient-support-programs-only-3-use-survey
https://consultqd.clevelandclinic.org/cleveland-clinics-virtual-emergency-medicine-program-treating-the-right-patients-in-the-right-place
SOURCE: Medisafe
View the original press release on ACCESS Newswire
Ch.Kahalev--AMWN